Giannis Mountzios: How Genomic Insights Are Shaping Early-Stage NSCLC Care
Giannis Mountzios/LinkedIn

Giannis Mountzios: How Genomic Insights Are Shaping Early-Stage NSCLC Care

Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant Hospital Center, shared a post on X:

“Just out in Cancers MDPI: Everything you need to know on Neoadj/Adjuv/Perioper treatment of Early-Stage NSCLC with AGAs soo proud of my mentee Dr Prodromos Koutoukoglou for this huge work.”

Tilte: Neoadjuvant, Adjuvant and Perioperative Treatment in Early-Stage Non-Small Cell Lung Cancer (NSCLC) with Actionable Genomic Alterations: Current Landscape and Future Perspectives

Authors: Prodromos Koutoukoglou, Giannis Mountzios

Read The Full Article

 NSCLC

More posts featuring Giannis Mountzios on OncoDaily.